Global Endometriosis Drugs Market 2019-2023| Availability of Patient Assistance Programs to Boost Growth| Technavio

Technavio has announced its latest market research report titled global endometriosis drugs market 2019-2023. (Graphic: Business Wire)

LONDON--()--The global endometriosis drugs market is expected to post a CAGR over 3% during the period 2019-2023, according to the latest market research report by Technavio. Request a free sample report

The rising focus on women's health is expected to boost the growth of the endometriosis drugs market size during the forecast period. Lack of awareness about several gynecological cancer indications such as endometriosis and endometrial cancer was a challenge for the growth of the market. However, various governmental authorities and organizations are working to raise awareness to overcome such challenges. For instance, the Office on Women’s Health (OWH), which is a part of the US Department of Health and Human Services (HHS), coordinates women’s health efforts and addresses critical women’s health issues by informing and advancing policies and educating healthcare professionals and consumers.

To learn more about the global trends impacting the future of market research, download free sample: https://www.technavio.com/talk-to-us?report=IRTNTR32107

As per Technavio, the availability of patient assistance programs will have a positive impact on the market and contribute to its growth significantly over the forecast period. This research report also analyzes other important trends and market drivers that will affect market growth over 2019-2023.

Global Endometriosis Drugs Market: Availability of Patient Assistance Programs

The endometriosis drugs market is dominated by high-cost hormone-based therapeutics, which is a major concern for patients. Thus, companies such as AbbVie and Bayer are providing patient-assistance programs to reduce the cost burden on patients. The availability of patient assistance programs for high-cost branded drugs will increase patient adherence to such drugs, which will positively impact the growth of the market during the forecast period.

“Apart from the availability of patient-assistance programs, other factors such as the robust pipeline, and the strategic alliances between vendors will have a significant impact on the growth of the endometriosis drugs market during the forecast period,says a senior analyst at Technavio.

Register for a free trial today and gain instant access to 10,000+ market research reports.

Technavio's SUBSCRIPTION platform

Global Endometriosis Drugs Market: Segmentation Analysis

This market research report segments the global endometriosis drugs market by product (hormone therapy, and analgesics) and by region (North America, Europe, Asia, and ROW).

The North American region led the market in 2018, followed by Europe, Asia, and ROW respectively. The growth of the endometriosis drugs market share in North America is driven by factors such as the high prevalence of endometriosis, advanced healthcare infrastructure, and the increasing adoption of hormone therapies for the treatment of endometriosis in the region.

Technavio’s sample reports are free of charge and contain multiple sections of the report, such as the market size and forecast, drivers, challenges, trends, and more.

Request a free sample report

Some of the key topics covered in the report include:

Market Landscape

  • Market ecosystem
  • Market characteristics
  • Market segmentation analysis

Market Sizing

  • Market definition
  • Market size and forecast

Five Forces Analysis

Market Segmentation

Geographical Segmentation

  • Regional comparison
  • Key leading countries

Market Drivers

Market Challenges

Market Trends

Vendor Landscape

  • Vendors covered
  • Vendor classification
  • Market positioning of vendors
  • Competitive scenario

About Technavio

Technavio is a leading global technology research and advisory company. Their research and analysis focuses on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions.

With over 500 specialized analysts, Technavio’s report library consists of more than 10,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio’s comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.

If you are interested in more information, please contact our media team at media@technavio.com.

Contacts

Technavio Research
 Jesse Maida
 Media & Marketing Executive
 US: +1 844 364 1100
 UK: +44 203 893 3200
 www.technavio.com

 

Release Summary

The global endometriosis drugs market is expected to post a CAGR over 3% during the period 2019-2023, according to Technavio.

Contacts

Technavio Research
 Jesse Maida
 Media & Marketing Executive
 US: +1 844 364 1100
 UK: +44 203 893 3200
 www.technavio.com